Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and Orientals
- 1 September 1980
- journal article
- letter
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 58 (9), 1142-1144
- https://doi.org/10.1139/y80-173
Abstract
The extent to which the antihypertensive debrisoquine (D) is metabolized to 4-hydroxydebrisoquine (4OHD) was influenced by the ethnic origin of the subjects. Following ingestion of 20 mg of debrisoquine sulfate, orientals excreted, on the average, significantly more D and less 4OHD in 0-8 h urine than caucasians; but the sums of D + 4OHD did not differ.This publication has 8 references indexed in Scilit:
- Deficient metabolism of debrisoquine and sparteineClinical Pharmacology & Therapeutics, 1980
- A method for studying drug metabolism in populations: Racial differences in amobarbital metabolismClinical Pharmacology & Therapeutics, 1979
- Debrisoquin hydroxylation polymorphism among Ghanaians and CaucasiansClinical Pharmacology & Therapeutics, 1979
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979
- Distinctive patterns of amobarbital metabolitesClinical Pharmacology & Therapeutics, 1978
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Determination of debrisoquin and its 4-hydroxy metabolite in plasma by gas chromatography/mass spectrometryAnalytical Chemistry, 1976
- Gas-liquid chromatographic electron capture determination of some monosubstituted guanido-containing drugsAnalytical Chemistry, 1975